Abstract-On the basis of monitoring the prevention of accumulation of lipid droplets in mouse 3T3-L1 preadipocyte cells and inhibition of the proliferation of human colon cancer HT-29 cells, effective anti-corpulence and anticancer compounds were isolated from the peel of Citrus fruits. These bioactive components were identified as polymethoxyflavones and coumarin derivatives by spectroscopic analyses. 5-hydroxy-6,7,8,3',4'-pentamethoxyflavone had the greatest anti-corpulence effects and 3,5,6,7,8,3',5'-heptamethoxyflavone had the greatest anticancer effects. Furthermore, distributions of those bioactive components in the peel of 10 species of Citrus fruits were demonstrated by HPLC analyses.
Identification and physiological evaluation of the components from

Introduction
Citrus fruits are known to be an abundant resource of compounds that might help prevent lifestyle-related diseases such as diabetes, high blood pressure and cancer [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . In recent years, many studies have focused on the anticancer properties of citrus components, especially polymethoxyflavones and their glycosides [3, [5] [6] [7] [8] 12] . However, little is known about active components with anti-corpulence properties [13] . As a part of our investigation of natural products with beneficial properties, we investigated the compounds with anti-corpulence and anticancer activities in citrus fruits. This paper considers the isolation and structure determination of the bioactive constituents with anti-corpulence and anticancer activities from the peel of citrus fruits, such as C. tachibana, C. kinokuni, and C. canaliculata. Distributions of the components with anti-corpulence and anticancer activities in the peel of several citrus species were also examined.
Results and Discussion
The mature fruits of 17 species of Citrus listed in Table 1 were collected from the "Citrus Park" of Onomichi-city, Hiroshima Prefecture, Japan during December to February. The peel and juice of the citrus fruits were separated. They were extracted with ethanol (EtOH). Therefore, the peel extracts of C. canaliculata, seedling sp. of C. tamurana, C. kinokuni and C. tachibana were further investigated. These EtOH extracts were partitioned between ethyl acetate (EtOAc) and water. The bioassay showed that the EtOAc-soluble fraction had stronger anticorpulence and anticancer activities compared with the water-soluble fraction, as shown in Table 2 . Next, on the basis of the assays for anti-corpulence and anticancer activities, the EtOAc-soluble fractions were further separated by column chromatography on silica gel and HPLC on ODS column to generate ten compounds (1-10). Compounds 1-6 have strong anti-corpulence and anticancer activities, and compounds 7 and 8 show only anticancer activity. Compounds 1-6 were mainly isolated from the EtOAc-soluble fractions of seedling sp. of C. tamurana, C. tachibana and C. kinokuni, and compounds 7-10 were isolated from C. canaliculata. [4, 20] , 5-hydroxypsoralen (9) [4] , and 8-hydroxypsoralen (10) [4] .
The biological activities of the purified compounds 1-10 were assessed and inhibition of lipid droplet accumulation in mouse 3T3-L1 preadipocyte cells (anti-corpulence activity) and inhibition of proliferation of human colon cancer HT-29 cells (anticancer activity) were measured using hesperidin (11) as a reference compound for biological activity. The IC 50 values for these inhibition effects are shown in Table 3 . Polymethoxyflavones, compounds 1-6, exhibited significantly high anticorpulence and anticancer activities, whereas coumarin derivatives, compounds 7 and 8, showed only anticancer activity. 5-hydroxy-6,7,8,3',4'-pentamethoxyflavone (1) had the greatest anti-corpulence activity and 3,5,6,7,8,3',4'-heptamethoxyflavone (3) had the greatest anticancer activity. In addition, none of the tested compounds had cytotoxic effects on the tested cells, as evident by no changes in the numbers of viable cells after 1 day of treatment. Distribution of these bioactive flavones and coumarins in the peels of ten species of citrus fruits was analyzed by HPLC. As shown in Table 4 , the polymethoxyflavones, compounds 1-6, were abundant in the peels of Chance seedling of C. amurana (#11), C. kinokuni (#14), C. tachibana (#15) and C. leiocarpa (#16), whereas coumarin derivatives, compounds 7 and 10, were in those of C. hassaku (#5) and C. canaliculata (#7). However, contents of polymethoxyflavones 1-6 in the peels of C. limon (#3) were very low, although the peel extract had the strong anti-corpulence activity, as shown in Fig. 1 . This might mean that the peels of C. limon contain the other active components.
Experimental
General experimental procedures
Analytical and preparative TLCs were carried out on glass sheets (0.25 mm and 0.5 mm) coated with silica gel (Merck silica gel 60; GF 254) and column chromatography was performed on silica gel column (Merck silica gel 60; 230-400 mesh) using a gradient solvent of 0-50% EtOAc in hexane. HPLC assays were performed using an ODS-3 column (3 mm x 25 cm) equipped with a UV detector at 254 nm and using a gradient solvent of 50-70% MeOH in H 2 O. H-NMR (500 MHz), 13 C-NMR (125 MHz), and 2D-NMR spectra were recorded using a JEOL LA500 spectrometer. Fast Atom Bombardment Mass Spectroscopy (FABMS) was measured on a JEOL SX102A spectrometer.
Cell cultures
Human colon cancer HT-29 cells, mouse 3T3-L1 preadipocyte cells, and human embryonic kidney (HEK) 293 cells were maintained in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% fetal calf serum, 100 units/ml penicillin, and 100 μg/ml streptomycin (maintenance medium) at 37°C in 5% CO 2 .
Materials
The 17 species of citrus fruits (Table 1) were cultivated and collected at the Citrus Park in Setoda-cyo, Onomichi-city, Hiroshima Prefecture, Japan, during the period December to February of 2005-2007. Hesperidin (11) was purchased from Sigma Chemical Co., Ltd.
Extraction and isolation
Fresh fruits were separated into the peel and juice vesicle parts. These were homogenized using a blender, soaked in ethanol (EtOH), and then extracted by 1-month treatment under dark and cool conditions. After filtration, each extract was concentrated in vacuo and these extracts were analyzed by bioassays (the anti-corpulence with 3T3-L1 preadipocytes mouse cells and the anticancer with human colon cancer HT-29 cells), as shown in Figures 1 and 2 . Among the extracts that showed good activities, the peel extracts of C. canaliculata (#7), and seedling sp. of C. tamurana (#11), C. kinokuni (#14) and C. tachibana (#15) were further separated into ethyl acetate (EtOAc)-and water-soluble fractions. C-NMR and FABMS and comparison of these data with reported data [4, 7, 9, 16, 17, 20] . These compounds were further purified by preparative HPLC with an ODS-3 column using 50-70% MeOH in H 2 O, and used for final bioassays ( Table 3 ).
The distribution of the bioactive compounds 1-8 in the EtOAc extracts from the peel of several citrus fruits were analyzed by HPLC with an ODS-3 column using 50-70% MeOH in H 2 O. The results are summarized in Table 4 .
Assay of adiposity differentiation.
For differentiation assays, confluent 3T3-L1 cells were cultured in differentiation media (maintenance media plus 0.5 mM 3-isobutyl-1-methylxanthine [IBMX], 5 μg/ml insulin and 1 μM dexamethasone [DEX]) for 2 days. Then, differentiation media was replaced with adipocyte growth media (maintenance media supplemented with 5 μg/ml insulin) with or without each compound, which was changed every 2 days. Differentiated 3T3-L1 cells were fixed with 4% buffered paraformaldehyde for 15 min. A stock solution of 0.3% Oil-Red-O (Sigma) in isopropanol (w/v) was diluted 6:4 prepared in water, filtered, and added to fixed cells. Cells were washed twice in phosphate-buffered saline (PBS) and photographed. The cells were solubilized with 1% Nonidet P-40 (Sigma) in isopropanol, and quantified by measuring the absorbance at 520 nm. The assays were carried out five times for each sample and the data are expressed to the mean percentage of lipid droplet accumulation as compared to the respective control experiment. A statistical deviation was less than 10%.
Anticancer assay.
HT-29 cells (human colon cancer cell line, American Type Culture Collection) were routinely cultured in Dulbecco's modified Eagle's medium-high glucose (Sigma) containing 10% bovine calf serum in a 5% CO 2 humidified environment at 37°C. 50 units/ml penicillin and 50 µg/ml streptomycin were added to the media. The cells were plated at a density of 8,000 cells/well on 96-well plates in 100 μl of fresh media and assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 24 h after plating, the cell media was exchanged with 100 μl of dimethylsulfoxide (Me 2 SO) solution containing 10% bovine calf serum and the indicated compound. After 72 h cultivation, 10 µl of MTT 5 mg/ml was added to each well and incubated for a further 4 h. The formazan crystals resulting from mitochondrial enzymatic activity of the MTT substrate were solubilized with Me 2 SO. Absorbance was measured at 550 nm using a microplate reader (TFB). Cell number was expressed as absorbance relative to that of untreated controls. The assays were carried out ten times for each sample and the data are expressed to the mean percentage of viable cells as compared to the respective control experiment. A statistical deviation was less than 10%.
